- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04451681
Evaluation of Physical Performance in Ankylosing Spondylitis Patients
Evaluation of Physical Performance in Ankylosing Spondylitis Patients by Cardiopulmonary Exercise Test
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
AS is an inflammatory disease of unknown etiology, characterized by marked inflammation in the spinal joints and adjacent structures, leading to progressive and ascending bone fusion in the spine. Although peripheral joint involvement is less, hip and shoulder joints are kept in 1/3 of the cases. Inflammatory lesions can also be seen in extraarticular organs such as eyes and heart. Due to joint involvement, limitations in lung capacity, and other extra-articular involvements, physical performance may decrease in AS patients. Both spinal and peripheral joint involvements and pain caused by chronic inflammatory process can lead patients to a more sedentary lifestyle. Therefore, evaluation of physical performance is important in patients with AS. Although there are some methods based on classical observation in evaluating physical performance, Cardiopulmonary Exercise Test (KPET), where objective data about aerobic capacity can be obtained, has been used frequently in scientific studies in recent years. The data such as oxygen consumption, cardiac parameters and speed of the patient on the treadmill in KPET are analyzed numerically; objective performance values such as maximum oxygen use (VO2max), maximum heart rate, and maximum rate can be achieved. It is possible to evaluate all the individuals to whom these tests are applied according to the normal value ranges in the world more clearly in terms of their physical performance and to reshape the exercise program especially according to the missing parameter. For this reason, these methods are preferred primarily in physical performance evaluation in centers with sufficient facilities.
In the literature, although subjective tests and data on physical performance decrease, studies showing clear numerical data are needed. Therefore, in our study; We aim to evaluate the physical performance of patients by applying KPET in our patients with AS diagnosis. Thus, investigators aim to reveal the physical exercise capacity that may be decreased in this patient group with objective numerical data. In addition, patients data will compare with the control group of similar physical characteristics and age.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Bezmialem Vakif University
-
İstanbul, Turkey
- BezmialemVU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of AS with modified New York Criteria (for AS group)
- Being between the ages of 18-65
- Agree to participate in the study
Exclusion Criteria:
- Cardiac disease
- History of stroke
- Asthma or chronic obstructive pulmonary disease
- Deformity that may prevent exercise
- Hypertension
- Unwilling to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Ankylosing spondylitis
A total of 42 patients, who were diagnosed with AS with modified New York Criteria, and who agreed to participate in the study, will be included in this group.
|
Data such as oxygen consumption, cardiac parameters and speed of the patient are analyzed numerically on the treadmill in the KPET; Objective performance values such as maximum oxygen use (VO2max), maximum heart rate, respiratory capacity, and maximum rate will be obtained.
|
|
Other: Control
A total of 42 control participants between the ages of 18-65 who agreed to participate in the study will be included in this group.
|
Data such as oxygen consumption, cardiac parameters and speed of the patient are analyzed numerically on the treadmill in the KPET; Objective performance values such as maximum oxygen use (VO2max), maximum heart rate, respiratory capacity, and maximum rate will be obtained.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
36-Item Short Form Health Survey (SF-36)
Time Frame: Ten minutes
|
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The eight sections are: vitality,physical functioning,bodily pain,general health perceptions,physical role,functioning,emotional role functioning,social role functioning and mental health. |
Ten minutes
|
|
Bath Ankylosing Spondylitis Disease Activation Index (BASDAI)
Time Frame: Ten minutes
|
The BASDAI or Bath Ankylosing Spondylitis Disease Activity Index is a validated diagnostic test which allows a physician, usually a rheumatologist, to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of Ankylosing spondylitis (AS).The BASDAI consists of a 0 - 10 scale measuring discomfort, pain, and fatigue (0 being no problem and 10 being the worst problem) in response to six questions asked of the patient pertaining to the five major symptoms of AS:Fatigue, Spinal pain, Arthralgia (joint pain) or swelling, Enthesitis,Morning stiffness duration, Morning stiffness severity
|
Ten minutes
|
|
Maximum Oxygen use (VO2max)
Time Frame: 60 minutes
|
VO2 max is the maximum rate of oxygen consumption measured during incremental exercise; that is, exercise of increasing intensity. The measurement of VO2 max in the laboratory provides a quantitative value of endurance fitness for comparison of individual training effects and between people in endurance training. Maximal oxygen consumption reflects cardiorespiratory fitness and endurance capacity in exercise performance. VO2 max refers to the amount of oxygen a person uses during intense or maximal exercise. Its measurement gives the amount of oxygen consumed per minute for a kilogram of body weight in milliliters. |
60 minutes
|
|
Maximum heart rate
Time Frame: One minutes
|
It is determined by measuring the maximum number of heartbeats observed per minute reached during the KPET.
|
One minutes
|
|
Maximum speed
Time Frame: One minutes
|
It is determined by measuring the maximum average distance traveled per minute on the treadmill in meters / minute.
|
One minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BVUFTRAS1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankylosing Spondylitis
-
Tongji HospitalNovartis; Johns Hopkins Bloomberg School of Public Health; Wuhan Central Hospital and other collaboratorsRecruitingAnkylosing Spondylitis (AS)China
-
Saglik Bilimleri UniversitesiRecruitingAnkylosing SpondylitisTurkey (Türkiye)
-
Henan Provincial People's HospitalThe Second Affiliated Hospital of Henan University of Traditional Chinese...Withdrawn
-
SPH-BIOCAD (HK) LimitedCompleted
-
China-Japan Friendship HospitalThe Second Affiliated Hospital of Henan University of Traditional Chinese...Recruiting
-
Shenzhen Huishan Biotechnology Co., Ltd.Southern Medical University, ChinaNot yet recruiting
-
Lynk Pharmaceuticals Co., LtdRecruitingAnkylosing SpondylitisChina
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
AbbVieBoehringer IngelheimCompletedAnkylosing Spondylitis (AS)
Clinical Trials on Cardiopulmonary exercise test
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
University of HullSheffield Hallam UniversityTerminated
-
Virginia Commonwealth UniversityNovartis PharmaceuticalsCompletedPrior Acute Myocardial Infarction | Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) | Reduced Left Ventricle Ejection Fraction (<50%) | Symptoms of Heart Failure (NYHA Class II-III)United States
-
The Clatterbridge Cancer Centre NHS Foundation...University of Liverpool Cancer Research CentreNot yet recruiting
-
York Teaching Hospitals NHS Foundation TrustUniversity of York; York St John UniversityCompletedInflammatory Response | Immune SystemUnited Kingdom
-
Chang Gung Memorial HospitalCompletedComorbid Chronic Lung Disease on Heart Failure
-
Hasselt UniversityCompletedCoronary Artery Bypass SurgeryBelgium
-
Wissenschaftliches Institut Bethanien e.VRoche Pharma AGCompleted
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous MalformationsUnited Kingdom
-
Rambam Health Care CampusRecruiting